Qsymeia-Weight loss drug was launched in late Sept.--,today Express Script-largest pharmacy service-agreed to sell Qsymia. Since that news-VVUS stock is on fire-up 9% so far today.
VVUS stock went thru 2 set backs-- one that Europe will not approve this drug. Second overhang is possible lawsuit .The stock went down,but today sharp rise means that investors are focusing on Sales and Earnings.
As soon as Vascepa becomes available for selling--Amarin stock should go up steadily.If Lipitor sales history is any similarity--when Warner Lambert stock went up from 46$ per share before launch in 1996 to 152$/share in the end of 1997. UP 330%
I am ready for the buy out or a longer wait without one. Either way I see "NO" negative to owning Amarin shares. It will be going up near or longer term. There is really nothing to stop it at this point with our without NCE even.
I predict a buyout though. I think all the signs are pointing to this ... especially since Amarin isn't gearing up (at all) to go it alone.